ALK and neoplasm: We report a 71 year-old male patient diagnosed with advanced lung adenocarcinoma lacking key driving genes (<i>EGFR</i>, <i>ALK</i>, and <i>ROS-1</i>), and low expression of PD-L1 on tumor cells (10-15%).